
On Friday, the US Biomedical Advanced Research and Development Authority (BARDA) placed an order for an additional 2.5 million doses of Jynneos, reported Danish vaccine maker Bavarian Nordic in a press release.
Based on this new and other recent vaccine orders, Bavarian Nordic has upgraded its financial expectations for 2022.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app